outfox

Funds / institutions · SEC Form 13F

What institutions reported holding

Search 381,214 reported position rows across 20 reporting entities and their collected quarters. Explore the holdings behind the names.

Collection dates and how to read these holdings

Partial manager coverage. Form 13F reports quarter-end holdings, usually filed later; not exact trades, transaction dates, current portfolios or ETF constituent data. Short positions, some securities, confidential holdings and unreviewed amendments may be absent. CUSIP and issuer names are preserved as filed; ticker/issuer-CIK matching is not inferred. Values use the SEC filing-date format (USD from January 3, 2023; thousands of USD before). Available valid filings are searchable even without comparison quarters. Combination reports and confidential-omission flags describe incomplete reported portfolios; only disclosed positions are shown, with no inferred missing holdings. Separate reporting entities remain separate. The latest quarter is partial as filings arrive; earlier reviewed snapshots remain searchable.

51 source-checked filings. A reported portfolio snapshot—not executed trades. Histories may be incomplete; missing data does not mean no holdings. Featured investor names identify associated management firms, not personal portfolios.

  • Third Point LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:43.118Z
  • APPALOOSA LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:41.303Z
  • VANGUARD GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:55.910Z
  • TWO SIGMA INVESTMENTS, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:27.467Z
  • Pershing Square Capital Management, L.P.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:37.679Z
  • STATE STREET CORP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:58.075Z
  • COATUE MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:31.488Z
  • TIGER GLOBAL MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:33.886Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:25.387Z
  • GOLDMAN SACHS GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:08.805Z
  • Bridgewater Associates, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:29.574Z
  • Duquesne Family Office LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:45.054Z
  • JPMORGAN CHASE & CO: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:03.721Z
  • TCI FUND MANAGEMENT LTD: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:46.863Z
  • PERSHING SQUARE INC.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:39.481Z
  • Altimeter Capital Management, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:35.674Z
  • MORGAN STANLEY: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:12.934Z
  • FMR LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:00.998Z
  • Berkshire Hathaway Inc: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:54.052Z
  • CITADEL ADVISORS LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:21.575Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:59.260Z
  • MORGAN STANLEY: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:53.319Z
  • STATE STREET CORP: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:33.733Z
  • JPMORGAN CHASE & CO: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:48.410Z

Reported positions

381,214 matching source rows · Page 917 of 15,249. A security can appear in multiple quarters or reporting entities.

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$72,229,630
Reported shares
522079
Source units and reporting details

Value as filed: 72229630 USD. Discretion code: DFND. Filing-local manager numbers: 8. Voting authority: sole 479573, shared 22399, none 20107.

Included managers attributed to this row:

  • JPMorgan Asset Management (UK) Ltd · 13F file 028-11947

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$594,724,774
Reported shares
4293057
Source units and reporting details

Value as filed: 594724774 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 3856537, shared 0, none 436520.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$277
Reported shares
2
Source units and reporting details

Value as filed: 277 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 2, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$51,466
Reported shares
372
Source units and reporting details

Value as filed: 51466 USD. Discretion code: DFND. Filing-local manager numbers: 24. Voting authority: sole 372, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan SE · 13F file 028-23287

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$16,295,001
Reported shares
117781
Source units and reporting details

Value as filed: 16295001 USD. Discretion code: DFND. Filing-local manager numbers: 16. Voting authority: sole 117781, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (Japan) Ltd · 13F file 028-14958

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$8,501,054
Reported shares
61446
Source units and reporting details

Value as filed: 8501054 USD. Discretion code: DFND. Filing-local manager numbers: 27. Voting authority: sole 61446, shared 0, none 0.

Included managers attributed to this row:

  • J.P. MORGAN MANSART MANAGEMENT Ltd · 13F file 028-24651

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,065,248
Reported shares
7699
Source units and reporting details

Value as filed: 1065248 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 7699.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$999,579
Reported shares
7225
Source units and reporting details

Value as filed: 999579 USD. Discretion code: DFND. Filing-local manager numbers: 10. Voting authority: sole 7225, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Asset Management (Canada) Inc. · 13F file 028-14957

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$3,320
Reported shares
24
Source units and reporting details

Value as filed: 3320 USD. Discretion code: DFND. Filing-local manager numbers: 23. Voting authority: sole 24, shared 0, none 0.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

COMMON · CUSIP 64125C109

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$385,305
Reported shares
2785
Source units and reporting details

Value as filed: 385305 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 2785, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

OPTION · CUSIP 64125C909

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$5,201,960
Reported shares
37600 · Call option
Source units and reporting details

Value as filed: 5201960 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 37600, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROCRINE BIOSCIENCES INC

OPTION · CUSIP 64125C959

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$2,296,610
Reported shares
16600 · Put option
Source units and reporting details

Value as filed: 2296610 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 16600, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROGENE INC

COMMON · CUSIP 64135M105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,436,278
Reported shares
50591
Source units and reporting details

Value as filed: 1436278 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 45957, shared 0, none 4634.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROGENE INC

COMMON · CUSIP 64135M105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$272,913
Reported shares
9613
Source units and reporting details

Value as filed: 272913 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 2168, shared 0, none 7445.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROGENE INC

COMMON · CUSIP 64135M105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$49,654
Reported shares
1749
Source units and reporting details

Value as filed: 49654 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 1749, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEURONETICS INC

COMMON · CUSIP 64131A105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$7,904
Reported shares
3349
Source units and reporting details

Value as filed: 7904 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 3349, shared 0, none 0.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEURONETICS INC

COMMON · CUSIP 64131A105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,765
Reported shares
748
Source units and reporting details

Value as filed: 1765 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 748, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROONE MED TECHNOLOGIES CO

COMMON · CUSIP 64130M308

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$96
Reported shares
88
Source units and reporting details

Value as filed: 96 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 88, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROPACE INC

COMMON · CUSIP 641288105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$16,129
Reported shares
1157
Source units and reporting details

Value as filed: 16129 USD. Discretion code: DFND. Filing-local manager numbers: 6. Voting authority: sole 1157, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities plc · 13F file 028-12006

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROPACE INC

COMMON · CUSIP 641288105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,531,685
Reported shares
109877
Source units and reporting details

Value as filed: 1531685 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 109877, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROPACE INC

COMMON · CUSIP 641288105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$174,975
Reported shares
12552
Source units and reporting details

Value as filed: 174975 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 12552.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROPACE INC

COMMON · CUSIP 641288105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$23,238
Reported shares
1667
Source units and reporting details

Value as filed: 23238 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 1667.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROPACE INC

COMMON · CUSIP 641288105

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$403,953
Reported shares
28978
Source units and reporting details

Value as filed: 403953 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 28978, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUROSENSE THERAPEUTICS LTD

COMMON · CUSIP M74240207

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$5
Reported shares
1
Source units and reporting details

Value as filed: 5 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 1, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

NEUTRON HOLDINGS INC

COMMON · CUSIP 64125S104

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$96,264
Reported shares
3386
Source units and reporting details

Value as filed: 96264 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 3386.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗